{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:46:06Z","timestamp":1765233966544,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":56,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071644294"},{"type":"electronic","value":"9781071644300"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4430-0_4","type":"book-chapter","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:15:19Z","timestamp":1742310919000},"page":"85-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Endothelial Activation and Stress Index (EASIX): A Prognostic Marker for Mortality After Acute Graft-Versus-Host Disease and Endothelial Complications"],"prefix":"10.1007","author":[{"given":"Thomas","family":"Luft","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","volume":"19","author":"S Dietrich","year":"2013","unstructured":"Dietrich S, Falk CS, Benner A et al (2013) Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment. Biol Blood Marrow Transplant 19:22\u201327","journal-title":"Biol Blood Marrow Transplant"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1182\/blood-2006-01-0254","volume":"108","author":"WM Leisenring","year":"2006","unstructured":"Leisenring WM, Martin PJ, Petersdorf EW et al (2006) An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood 108:749\u2013755","journal-title":"Blood"},{"key":"4_CR3","first-page":"1","volume":"9","author":"NH Kim","year":"2024","unstructured":"Kim NH, Hamadani M, Abedin S (2024) New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literature. Expert Opin Investig Drugs 9:1\u20139","journal-title":"Expert Opin Investig Drugs"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1182\/blood-2006-10-049817","volume":"110","author":"T Luft","year":"2007","unstructured":"Luft T, Conzelmann M, Benner A et al (2007) Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease. Blood 110:4535\u20134542","journal-title":"Blood"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","volume":"118","author":"T Luft","year":"2011","unstructured":"Luft T, Dietrich S, Falk C et al (2011) Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system. Blood 118:1685\u20131692","journal-title":"Blood"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1038\/s41375-018-0183-0","volume":"32","author":"S Sauer","year":"2018","unstructured":"Sauer S, Husing J, Hajda J et al (2018) A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHD. Leukemia 32:2685\u20132692","journal-title":"Leukemia"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3324\/haematol.2011.061051","volume":"97","author":"M Andrulis","year":"2012","unstructured":"Andrulis M, Dietrich S, Longerich T et al (2012) Loss of endothelial thrombomodulin predicts response to steroid therapy and survival in acute intestinal graft-versus-host disease. Haematologica 97:1674\u20131677","journal-title":"Haematologica"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1182\/bloodadvances.2018020321","volume":"2","author":"SA Wall","year":"2018","unstructured":"Wall SA, Zhao Q, Yearsley M et al (2018) Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD. Blood Adv 2:2619\u20132628","journal-title":"Blood Adv"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/bmt.2017.119","volume":"52","author":"M Zeisbrich","year":"2017","unstructured":"Zeisbrich M, Becker N, Benner A et al (2017) Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD. Bone Marrow Transplant 52:1399\u20131405","journal-title":"Bone Marrow Transplant"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/s41409-021-01390-y","volume":"56","author":"T Luft","year":"2021","unstructured":"Luft T, Dreger P, Radujkovic A (2021) Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation. Bone Marrow Transplant 56:2326\u20132335","journal-title":"Bone Marrow Transplant"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","volume":"29","author":"S Jodele","year":"2014","unstructured":"Jodele S, Laskin BL, Dandoy CE et al (2014) A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 29:191\u2013204","journal-title":"Blood Rev"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","volume":"92","author":"T Ruutu","year":"2007","unstructured":"Ruutu T, Barosi G, Benjamin RJ et al (2007) Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 92:95\u2013100","journal-title":"Haematologica"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","volume":"67","author":"CM Nester","year":"2015","unstructured":"Nester CM, Barbour T, de Cordoba SR et al (2015) Atypical aHUS: state of the art. Mol Immunol 67:31\u201342","journal-title":"Mol Immunol"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1016\/S2352-3026(17)30108-4","volume":"4","author":"T Luft","year":"2017","unstructured":"Luft T, Benner A, Jodele S et al (2017) EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis. Lancet Haematol 4:e414\u2013e423","journal-title":"Lancet Haematol"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1007\/s00134-023-07193-7","volume":"49","author":"F Korell","year":"2023","unstructured":"Korell F, DeFilipp Z, Schreck N, Luft T (2023) Validation of EASIX for prediction of sepsis after allogeneic stem cell transplantation. Intensive Care Med 49:1408\u20131410","journal-title":"Intensive Care Med"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00134-022-06676-3","volume":"48","author":"F Korell","year":"2022","unstructured":"Korell F, Schreck N, Muller-Tidow C, Dreger P, Luft T, Taskforce Allogeneic Stem Cell Transplantation UHH (2022) Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation. Intensive Care Med 48:753\u2013755","journal-title":"Intensive Care Med"},{"key":"4_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007635","volume":"12","author":"O Penack","year":"2024","unstructured":"Penack O, Luft T, Peczynski C et al (2024) Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study. J Immunother Cancer 12:e007635","journal-title":"J Immunother Cancer"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/s41409-022-01829-w","volume":"57","author":"A Baranwal","year":"2022","unstructured":"Baranwal A, Mangaonkar A, Shah MV et al (2022) High EASIX score is an independent predictor of non-relapse mortality in patients with CMML undergoing allogeneic stem cell transplant. Bone Marrow Transplant 57:1842\u20131844","journal-title":"Bone Marrow Transplant"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s41409-020-01186-6","volume":"56","author":"H Dai","year":"2021","unstructured":"Dai H, Penack O, Radujkovic A et al (2021) Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication. Bone Marrow Transplant 56:1573\u20131583","journal-title":"Bone Marrow Transplant"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jcyt.2023.10.008","volume":"26","author":"S Escribano-Serrat","year":"2024","unstructured":"Escribano-Serrat S, Rodriguez-Lobato LG, Charry P et al (2024) Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis. Cytotherapy 26:73\u201380","journal-title":"Cytotherapy"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/s41409-024-02267-6","volume":"59","author":"S Escribano-Serrat","year":"2024","unstructured":"Escribano-Serrat S, Rodriguez-Lobato LG, Suarez-Lledo M et al (2024) Improving the EASIX\u2019 predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 59:1022\u20131024","journal-title":"Bone Marrow Transplant"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"580.e581","DOI":"10.1016\/j.jtct.2023.06.021","volume":"29","author":"S Fujita","year":"2023","unstructured":"Fujita S, Monna-Oiwa M, Kato S et al (2023) Pretransplantation EASIX score predicts nonrelapse and overall mortality of adult patients undergoing single-unit unrelated cord blood transplantation. Transplant Cell Ther 29:580.e581\u2013580.e588","journal-title":"Transplant Cell Ther"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3324\/haematol.2019.238790","volume":"106","author":"S Jiang","year":"2020","unstructured":"Jiang S, Penack O, Terzer T et al (2020) Predicting sinusoidal obstruction syndrome after allogeneic stem cell transplantation with the EASIX biomarker panel. Haematologica 106:446\u2013453","journal-title":"Haematologica"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1182\/bloodadvances.2022008617","volume":"7","author":"L Kordelas","year":"2023","unstructured":"Kordelas L, Terzer T, Gooley T et al (2023) EASIX-1year and late mortality after allogeneic stem cell transplantation. Blood Adv 7:5374\u20135381","journal-title":"Blood Adv"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41409-019-0703-1","volume":"55","author":"T Luft","year":"2020","unstructured":"Luft T, Benner A, Terzer T et al (2020) EASIX and mortality after allogeneic stem cell transplantation. Bone Marrow Transplant 55:553\u2013561","journal-title":"Bone Marrow Transplant"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41409-022-01874-5","volume":"58","author":"J Mariotti","year":"2022","unstructured":"Mariotti J, Magri F, Giordano L et al (2022) EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide. Bone Marrow Transplant 58:247\u2013256","journal-title":"Bone Marrow Transplant"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1182\/bloodadvances.2022007381","volume":"6","author":"MT Nawas","year":"2022","unstructured":"Nawas MT, Sanchez-Escamilla M, Devlin SM et al (2022) Dynamic EASIX scores closely predict nonrelapse mortality after allogeneic hematopoietic cell transplantation. Blood Adv 6:5898\u20135907","journal-title":"Blood Adv"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"187.e181","DOI":"10.1016\/j.jtct.2023.11.016","volume":"30","author":"A Pedraza","year":"2024","unstructured":"Pedraza A, Salas MQ, Rodriguez-Lobato LG et al (2024) Easix score correlates with endothelial dysfunction biomarkers and predicts risk of acute graft-versus-host disease after allogeneic transplantation. Transplant Cell Ther 30:187.e181\u2013187.e112","journal-title":"Transplant Cell Ther"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1182\/bloodadvances.2021004812","volume":"5","author":"M Pena","year":"2021","unstructured":"Pena M, Salas MQ, Mussetti A et al (2021) Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation. Blood Adv 5:3418\u20133426","journal-title":"Blood Adv"},{"key":"4_CR30","first-page":"S2531","volume":"12","author":"MQ Salas","year":"2023","unstructured":"Salas MQ, Rodriguez-Lobato LG, Charry P et al (2023) Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era. Hematol Transfus Cell Ther 12:S2531\u2013S1379","journal-title":"Hematol Transfus Cell Ther"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41409-023-01922-8","volume":"58","author":"M Sanchez-Escamilla","year":"2023","unstructured":"Sanchez-Escamilla M, Flynn J, Devlin S et al (2023) EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 58:498\u2013505","journal-title":"Bone Marrow Transplant"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1182\/bloodadvances.2019032268","volume":"3","author":"R Shouval","year":"2019","unstructured":"Shouval R, Fein JA, Shouval A et al (2019) External validation and comparison of multiple prognostic scores in allogeneic hematopoietic stem cell transplantation. Blood Adv 3:1881\u20131890","journal-title":"Blood Adv"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41409-024-02270-x","volume":"59","author":"C Tolosa-Ridao","year":"2024","unstructured":"Tolosa-Ridao C, Cascos E, Rodriguez-Lobato LG et al (2024) EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 59:974\u2013982","journal-title":"Bone Marrow Transplant"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbmt.2020.01.028","volume":"26","author":"A Varma","year":"2020","unstructured":"Varma A, Rondon G, Srour SA et al (2020) Endothelial activation and stress index (EASIX) at admission predicts fluid overload in recipients of allogeneic stem cell transplantation. Biol Blood Marrow Transplant 26:1013\u20131020","journal-title":"Biol Blood Marrow Transplant"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s12288-022-01623-0","volume":"39","author":"ZA Yegin","year":"2023","unstructured":"Yegin ZA, Savas EM, Yildiz S et al (2023) Preconditioning modified-EASIX as a predictor of prognosis in allogeneic hematopoietic stem cell transplant recipients. Indian J Hematol Blood Transfus 39:586\u2013597","journal-title":"Indian J Hematol Blood Transfus"},{"key":"4_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.877477","volume":"13","author":"F Korell","year":"2022","unstructured":"Korell F, Penack O, Mattie M et al (2022) EASIX and severe endothelial complications after CD19-directed CAR-T cell therapy-a cohort study. Front Immunol 13:877477","journal-title":"Front Immunol"},{"key":"4_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.736028","volume":"8","author":"F Perez-Garcia","year":"2021","unstructured":"Perez-Garcia F, Bailen R, Torres-Macho J et al (2021) Age-adjusted endothelial activation and stress index for coronavirus disease 2019 at admission is a reliable predictor for 28-day mortality in hospitalized patients with coronavirus disease 2019. Front Med (Lausanne) 8:736028","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"4_CR38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4046\/trd.2024.0081","volume":"87","author":"JH Jeong","year":"2024","unstructured":"Jeong JH, Heo M, Park S et al (2024) Association between age-adjusted Endothelial Activation and Stress Index and ICU mortality in patients with severe coronavirus disease-2019. Tuberc Respir Dis (Seoul) 87(4):524\u2013531","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1182\/bloodadvances.2020003885","volume":"5","author":"M Pennisi","year":"2021","unstructured":"Pennisi M, Sanchez-Escamilla M, Flynn JR et al (2021) Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells. Blood Adv 5:3397\u20133406","journal-title":"Blood Adv"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.3390\/cancers15225443","volume":"15","author":"JW de Boer","year":"2023","unstructured":"de Boer JW, Keijzer K, Pennings ERA et al (2023) Population-based external validation of the EASIX scores to predict CAR T-cell-related toxicities. Cancers (Basel) 15:5443","journal-title":"Cancers (Basel)"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00277-024-05617-y","volume":"103","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhang X, Zhang M et al (2024) Modified EASIX scores predict severe CRS\/ICANS in patients with acute myeloid leukemia following CLL1 CAR-T cell therapy. Ann Hematol 103:969\u2013980","journal-title":"Ann Hematol"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1186\/s12885-020-07317-y","volume":"20","author":"GY Song","year":"2020","unstructured":"Song GY, Jung SH, Kim K et al (2020) Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma. BMC Cancer 20:803","journal-title":"BMC Cancer"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1186\/s12885-022-09915-4","volume":"22","author":"S Park","year":"2022","unstructured":"Park S, Go SI, Lee GW (2022) The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma. BMC Cancer 22:816","journal-title":"BMC Cancer"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1007\/s00277-023-05437-6","volume":"102","author":"R Thanhakun","year":"2023","unstructured":"Thanhakun R, Wudhikarn K, Bunworasate U et al (2023) Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group. Ann Hematol 102:3533\u20133541","journal-title":"Ann Hematol"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/CBM-220032","volume":"35","author":"SI Go","year":"2022","unstructured":"Go SI, Park S, Kang MH et al (2022) Endothelial activation and stress index (EASIX) as a predictive biomarker in small cell lung cancer. Cancer Biomark 35:217\u2013225","journal-title":"Cancer Biomark"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4111\/icu.20220204","volume":"63","author":"JS Gu","year":"2022","unstructured":"Gu JS, Ryu JW, Yu SH et al (2022) Prognostic value of the endothelial activation and stress index in patients with upper tract urothelial cancer undergoing radical nephroureterectomy. Investig Clin Urol 63:623\u2013630","journal-title":"Investig Clin Urol"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.7150\/ijms.85870","volume":"20","author":"HB Xu","year":"2023","unstructured":"Xu HB, Ye Y, Xue F, Wu J, Suo Z, Zhang H (2023) Association between endothelial activation and stress index and 28-day mortality in septic ICU patients: a retrospective cohort study. Int J Med Sci 20:1165\u20131173","journal-title":"Int J Med Sci"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s40001-024-01899-0","volume":"29","author":"R Wang","year":"2024","unstructured":"Wang R, Jiang Y, He M, Xu J (2024) EASIX is an effective marker in predicting mortality of traumatic brain injury patients. Eur J Med Res 29:300","journal-title":"Eur J Med Res"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.3390\/jcm12072553","volume":"12","author":"D Schult","year":"2023","unstructured":"Schult D, Rasch S, Schmid RM, Lahmer T, Mayr U (2023) EASIX is an accurate and easily available prognostic score in critically ill patients with advanced liver disease. J Clin Med 12:2553","journal-title":"J Clin Med"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.3390\/jcm10194373","volume":"10","author":"E Kalicinska","year":"2021","unstructured":"Kalicinska E, Biernat M, Rybka J et al (2021) Endothelial Activation and Stress Index (EASIX) as an early predictor for mortality and overall survival in hematological and non-hematological patients with COVID-19: multicenter cohort study. J Clin Med 10:4373","journal-title":"J Clin Med"},{"key":"4_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.634416","volume":"12","author":"T Luft","year":"2021","unstructured":"Luft T, Wendtner CM, Kosely F et al (2021) EASIX for prediction of outcome in hospitalized SARS-CoV-2 infected patients. Front Immunol 12:634416","journal-title":"Front Immunol"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1182\/bloodadvances.2021004575","volume":"5","author":"U Greenbaum","year":"2021","unstructured":"Greenbaum U, Strati P, Saliba RM et al (2021) CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity. Blood Adv 5:2799\u20132806","journal-title":"Blood Adv"},{"key":"4_CR53","doi-asserted-by":"publisher","unstructured":"Finke D (2024) EASIX (Endothelial Activation and Stress Index) predicts mortality in patients with coronary artery disease. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-024-02534-y","DOI":"10.1007\/s00392-024-02534-y"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41408-019-0247-z","volume":"9","author":"A Merz","year":"2019","unstructured":"Merz A, Germing U, Kobbe G et al (2019) EASIX for prediction of survival in lower-risk myelodysplastic syndromes. Blood Cancer J 9:85","journal-title":"Blood Cancer J"},{"key":"4_CR55","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006429","volume":"2","author":"WC Aird","year":"2012","unstructured":"Aird WC (2012) Endothelial cell heterogeneity. Cold Spring Harb Perspect Med 2:a006429","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-0030-1253445","volume":"36","author":"WC Aird","year":"2010","unstructured":"Aird WC, Kwaan HC (2010) Under-recognized significance of endothelial heterogeneity: hemostasis, thrombosis, and beyond. Semin Thromb Hemost 36:225\u2013226","journal-title":"Semin Thromb Hemost"}],"container-title":["Methods in Molecular Biology","Graft-Versus-Host Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4430-0_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:15:23Z","timestamp":1742310923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4430-0_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071644294","9781071644300"],"references-count":56,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4430-0_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"19 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}